Securities Lawyer 101 Blog On May 16, 2014, the Securities and Exchange Commission (“SEC”) suspended trading in FusionPharm, Inc. (FSPM) for ten days. The reason given for the action was “questions that have been raised about... (1) the ...
http://www.securitieslawyer101.com/fusionpharm/
No comments:
Post a Comment